共 147 条
- [1] Tan BHL(2008)Cachexia: prevalence and impact in medicine Curr Opin Clin Nutr Metab Care 11 400-407
- [2] Fearon KCH(2008)Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer BJU Int 102 44-47
- [3] Galvão DA(2014)Cancer cachexia: understanding the molecular basis Nat Rev Cancer 14 754-762
- [4] Spry NA(2010)Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training J Cachexia Sarcopenia Muscle 1 9-21
- [5] Taaffe DR(2010)Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved? Int J Cancer 127 1706-1717
- [6] Argilés JM(2012)Cancer-related inflammation: common themes and therapeutic opportunities Semin Cancer Biol 22 33-40
- [7] Busquets S(2016)Redox control of skeletal muscle atrophy Free Radic Biol Med 98 208-217
- [8] Stemmler B(2015)Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study Oncol Rep 33 2261-2268
- [9] López-Soriano FJ(2002)Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress Cancer Lett 180 69-74
- [10] Lenk K(2009)Effect of creatine supplementation during cast-induced immobilization on the preservation of muscle mass, strength, and endurance J Strength Cond Res 23 116-120